Invivyd

Invivyd, FDA agree on steps to EUA for COVID monoclonal antibody

Invivyd and the FDA have agreed on a path toward potential emergency use authorization for the biotech's mAb designed to prevent symptomatic COVID-19.

Gabrielle Masson Jun 26, 2023 10:36am

change direction new plan alter arrows move reprioritize

Invivyd evolves yet again to keep pace with COVID-19

Mar 6, 2023 10:45am

Invivyd faces C-suite departures, commercial layoffs

Oct 14, 2022 10:29am